Advertisement

Tumor Biology

, Volume 36, Issue 10, pp 8041–8045 | Cite as

Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance

  • Shengqian Zhu
  • Jinqin Mao
  • Yongfu Shao
  • Fang Chen
  • Xiaoqin Zhu
  • Dingli Xu
  • Xinjun Zhang
  • Junming Guo
Research Article

Abstract

Long non-coding RNA (lncRNA), which is greater than 200 nucleotides, is a class of RNA molecules without protein coding function. In recent years, studies have shown that lncRNAs are associated with cancers. They are affecting the occurrence and development of cancers. However, the diagnostic significances of lncRNAs in gastric cancer are largely unknown. In this study, we focused on AI364715, one typical lncRNA. A total of 186 samples were collected from two cancer centers. To find the potential association between its level and gastric cancer, we first collected 75 paired gastric cancer tissues and normal tissues, which are 5 cm away from the edge of carcinoma. Besides, 18 human healthy gastric mucosa and 18 gastric precancerous lesions (dysplasia) were also collected. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was first used to detect the expression level of AI364715 at multiple stages of gastric tumorigenesis. Then, the relationships between AI364715 level and the clinicopathological factors of patients with gastric cancer were analyzed. The results showed that the expression level of AI364715 in gastric cancer tissues was downregulated. Meanwhile, its expression level was closely associated with tumor size and differentiation. More importantly, AI364715 expression level was significantly changed in dysplasia, the typical precancerous lesions. Taken together, AI364715 may be a potential biomarker for the diagnosis of gastric cancer.

Keywords

Long non-coding RNA AI364715 Gastric cancer Tumor marker 

Notes

Acknowledgments

This work was supported by the Zhejiang Provincial Natural Science Foundation of China (No. LY14C060003), the Applied Research Project on Nonprofit Technology of Zhejiang Province (No. 2014C33222), the National Natural Science Foundation of China (No. 81171660), the Scientific Innovation Team Project of Ningbo (No. 2011B82014), and the K. C. Wong Magna Fund in Ningbo University.

Conflicts of interest

None

References

  1. 1.
    Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, et al. Treatment of gastric cancer. World J Gastroenterol. 2014;20:1635–49.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27:2–12.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 2006;20:633–49.CrossRefPubMedGoogle Scholar
  4. 4.
    Chen WY, Cheng HC, Wang JD, Sheu BS. Factors that affect life expectancy of patients with gastric adenocarcinoma. Clin Gastroenterol Hepatol. 2013;11(12):1595–600.CrossRefPubMedGoogle Scholar
  5. 5.
    Pan L, He M, Ma J, Tang W, Gao G, He R, et al. Phase and size controllable synthesis of NaYbF4 nanocrystals in oleic acid/ionic liquid two-phase system for targeted fluorescent imaging of gastric cancer. Theranostics. 2013;3:210–22.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi Y, et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep. 2014;4:6088.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354–61.CrossRefPubMedGoogle Scholar
  8. 8.
    Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu Z, et al. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer. 2014;120:3320–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Vance KW, Sansom SN, Lee S, Chalei V, Kong L, Cooper SE, et al. The long non-coding RNA Paupar regulates the expression of both local and distal genes. EMBO J. 2014;33:296–311.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Qiu MT, Hu JW, Yin R, Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol. 2013;34:613–20.CrossRefPubMedGoogle Scholar
  11. 11.
    Song H, Sun W, Ye G, Ding X, Liu Z, Zhang S, et al. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med. 2013;11:225.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012;279:3159–65.CrossRefPubMedGoogle Scholar
  13. 13.
    Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene. 2007;26:851–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Inada R, Sekine S, Taniguchi H, Tsuda H, Katai H, Fujiwara T, et al. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status. World J Gastroenterol. 2015;21:2159–68.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol. 2014;35:5441–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology. 2006;44:1012–24.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011;71:6320–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol. 2009;21:688–92.CrossRefPubMedGoogle Scholar
  19. 19.
    Xiao B, Guo J. Long noncoding RNA AC096655.1-002 has been officially named as gastric cancer-associated transcript 1, GACAT1. Tumour Biol. 2013;34:3271.CrossRefPubMedGoogle Scholar
  20. 20.
    Sun W, Wu Y, Yu X, Liu Y, Song H, Xia T, et al. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Tumour Biol. 2013;34:2697–701.CrossRefPubMedGoogle Scholar
  21. 21.
    Chen S, Li P, Xiao B, Guo J. Long noncoding RNA HMlincRNA717 and AC130710 have been officially named as gastric cancer associated transcript 2 (GACAT2) and GACAT3, respectively. Tumour Biol. 2014;35:8351–2.CrossRefPubMedGoogle Scholar
  22. 22.
    Chen F, Tian Y, Pang EJ, Wang Y, Li L. MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer. Cancer Gene Ther. 2015. doi: 10.1038/cgt.2015.6.Google Scholar
  23. 23.
    Chen WM, Huang M, Kong R, Xu TP, Zhang EB, Xia R, et al. Antisense long noncoding RNA HIF1A-AS2 is upregulated in gastric cancer and associated with poor prognosis. Dig Dis Sci. 2015. doi: 10.1007/s10620-015-3524-0.Google Scholar
  24. 24.
    Zhou B, Jing XY, Wu JQ, Xi HF, Lu GJ. Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer. Int J Clin Exp Pathol. 2014;7:8893–8.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Jiang K, Zhu Y, Liu Y, Ye Y, Xie Q, Yang X, et al. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined. Tumour Biol. 2014;35:11685–90.CrossRefPubMedGoogle Scholar
  26. 26.
    Eom BW, Ryu KW, Nam BH, Park Y, Lee HJ, Kim MC, et al. Survival nomogram for curatively resected Korean gastric cancer patients: multicenter retrospective analysis with external validation. PLoS One. 2015;10, e0119671.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Xu C, Shao Y, Xia T, Yang Y, Dai J, Luo L, et al. lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis. Tumour Biol. 2014;35:9701–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Sakimura S, Sugimachi K, Kurashige J, Ueda M, Hirata H, Nambara S, et al. The miR-506-induced epithelial-mesenchymal transition is involved in poor prognosis for patients with gastric cancer. Ann Surg Oncol. 2015. doi: 10.1245/s10434-015-4418-2.Google Scholar
  29. 29.
    Isobe T, Hashimoto K, Kizaki J, Matono S, Murakami N, Kinugasa T, et al. Characteristics and prognosis of mucinous gastric carcinoma. Mol Clin Oncol. 2015;3:44–50.PubMedGoogle Scholar
  30. 30.
    Wang W, Dong LP, Zhang N, Zhao CH. Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis. Int J Clin Exp Med. 2014;7:5059–66.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Chen H, Shen DP, Zhang ZZ, Liu JH, Shen YY, Ni XZ. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer. World J Gastroenterol. 2015;21:1838–44.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Shengqian Zhu
    • 1
  • Jinqin Mao
    • 1
  • Yongfu Shao
    • 1
  • Fang Chen
    • 1
  • Xiaoqin Zhu
    • 1
  • Dingli Xu
    • 1
  • Xinjun Zhang
    • 2
  • Junming Guo
    • 1
  1. 1.Department of Biochemistry and Molecular Biology, Zhejiang Provincial Key Laboratory of PathophysiologyNingbo University School of MedicineNingboChina
  2. 2.Department of GastroenterologyThe Affiliated Hospital of Ningbo University School of MedicineNingboChina

Personalised recommendations